Royal Bank of Canada’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $97.4M | Sell |
531,377
-10,448
| -2% | -$1.93M | 0.02% | 637 |
|
|
2025
Q4 | $95.4M | Buy |
541,825
+43,705
| +9% | +$7.14M | 0.02% | 668 |
|
|
2025
Q3 | $69.8M | Buy |
498,120
+1,968
| +0.4% | +$266K | 0.01% | 856 |
|
|
2025
Q2 | $62.3M | Buy |
496,152
+165,590
| +50% | +$20.6M | 0.01% | 829 |
|
|
2025
Q1 | $45.2M | Buy |
330,562
+84,227
| +34% | +$12M | 0.01% | 844 |
|
|
2024
Q4 | $37.7M | Sell |
246,335
-96,859
| -28% | -$16.3M | 0.01% | 972 |
|
|
2024
Q3 | $66.5M | Sell |
343,194
-52,518
| -13% | -$11M | 0.01% | 694 |
|
|
2024
Q2 | $91.7M | Sell |
395,712
-7,566
| -2% | -$1.64M | 0.02% | 549 |
|
|
2024
Q1 | $87M | Buy |
403,278
+29,264
| +8% | +$6.85M | 0.02% | 573 |
|
|
2023
Q4 | $96.8M | Buy |
374,014
+67,460
| +22% | +$16.6M | 0.02% | 538 |
|
|
2023
Q3 | $78.8M | Sell |
306,554
-45,986
| -13% | -$12.3M | 0.02% | 536 |
|
|
2023
Q2 | $100M | Buy |
352,540
+65,659
| +23% | +$19.5M | 0.03% | 476 |
|
|
2023
Q1 | $79.8M | Sell |
286,881
-96,925
| -25% | -$26.8M | 0.02% | 522 |
|
|
2022
Q4 | $106M | Buy |
383,806
+131,377
| +52% | +$37.1M | 0.03% | 453 |
|
|
2022
Q3 | $67.4M | Sell |
252,429
-43,308
| -15% | -$9.2M | 0.02% | 547 |
|
|
2022
Q2 | $60.3M | Buy |
295,737
+33,466
| +13% | +$6.84M | 0.02% | 595 |
|
|
2022
Q1 | $55.2M | Sell |
262,271
-17,642
| -6% | -$3.84M | 0.01% | 703 |
|
|
2021
Q4 | $67.2M | Sell |
279,913
-11,106
| -4% | -$2.86M | 0.02% | 685 |
|
|
2021
Q3 | $82.4M | Sell |
291,019
-96,849
| -25% | -$31.7M | 0.02% | 560 |
|
|
2021
Q2 | $134M | Buy |
387,868
+36,132
| +10% | +$10.9M | 0.04% | 398 |
|
|
2021
Q1 | $98.4M | Sell |
351,736
-27,298
| -7% | -$7.36M | 0.03% | 461 |
|
|
2020
Q4 | $92.8M | Sell |
379,034
-40,757
| -10% | -$10.5M | 0.03% | 474 |
|
|
2020
Q3 | $119M | Buy |
419,791
+66,634
| +19% | +$18.6M | 0.04% | 350 |
|
|
2020
Q2 | $94.5M | Buy |
353,157
+55,578
| +19% | +$16.7M | 0.04% | 377 |
|
|
2020
Q1 | $94.1M | Sell |
297,579
-57,678
| -16% | -$17.5M | 0.05% | 312 |
|
|
2019
Q4 | $105M | Sell |
355,257
-11,471
| -3% | -$3.18M | 0.04% | 378 |
|
|
2019
Q3 | $85.4M | Buy |
366,728
+70,774
| +24% | +$16.5M | 0.03% | 406 |
|
|
2019
Q2 | $69.2M | Sell |
295,954
-86,858
| -23% | -$20.1M | 0.03% | 463 |
|
|
2019
Q1 | $90.5M | Sell |
382,812
-15,129
| -4% | -$4.76M | 0.04% | 374 |
|
|
2018
Q4 | $120M | Sell |
397,941
-50,494
| -11% | -$16.1M | 0.06% | 290 |
|
|
2018
Q3 | $158M | Sell |
448,435
-58,602
| -12% | -$20.2M | 0.07% | 247 |
|
|
2018
Q2 | $147M | Sell |
507,037
-140,283
| -22% | -$39.4M | 0.07% | 246 |
|
|
2018
Q1 | $177M | Buy |
647,320
+298,014
| +85% | +$92.5M | 0.08% | 208 |
|
|
2017
Q4 | $111M | Buy |
349,306
+48,832
| +16% | +$15.7M | 0.05% | 308 |
|
|
2017
Q3 | $94.1M | Buy |
300,474
+8,161
| +3% | +$2.42M | 0.05% | 322 |
|
|
2017
Q2 | $79.3M | Sell |
292,313
-56,973
| -16% | -$15.1M | 0.04% | 362 |
|
|
2017
Q1 | $95.5M | Sell |
349,286
-131,149
| -27% | -$37.1M | 0.05% | 292 |
|
|
2016
Q4 | $136M | Buy |
480,435
+106,448
| +28% | +$31.6M | 0.07% | 220 |
|
|
2016
Q3 | $117M | Buy |
373,987
+85,833
| +30% | +$25.4M | 0.07% | 246 |
|
|
2016
Q2 | $69.7M | Sell |
288,154
-11,672
| -4% | -$3.08M | 0.04% | 351 |
|
|
2016
Q1 | $78M | Sell |
299,826
-51,140
| -15% | -$13.5M | 0.05% | 312 |
|
|
2015
Q4 | $108M | Buy |
350,966
+119,437
| +52% | +$34.3M | 0.07% | 220 |
|
|
2015
Q3 | $67.6M | Sell |
231,529
-82,937
| -26% | -$27.4M | 0.05% | 260 |
|
|
2015
Q2 | $127M | Buy |
314,466
+61,571
| +24% | +$24.7M | 0.09% | 173 |
|
|
2015
Q1 | $107M | Sell |
252,895
-70,103
| -22% | -$27.6M | 0.07% | 190 |
|
|
2014
Q4 | $110M | Buy |
322,998
+31,205
| +11% | +$10.1M | 0.07% | 206 |
|
|
2014
Q3 | $96.5M | Buy |
291,793
+57,853
| +25% | +$19.1M | 0.07% | 217 |
|
|
2014
Q2 | $73.8M | Sell |
233,940
-9,557
| -4% | -$2.88M | 0.05% | 265 |
|
|
2014
Q1 | $74.5M | Sell |
243,497
-10,699
| -4% | -$3.4M | 0.05% | 251 |
|
|
2013
Q4 | $71.1M | Buy |
254,196
+47,181
| +23% | +$12.2M | 0.05% | 284 |
|
|
2013
Q3 | $49.8M | Sell |
207,015
-133,637
| -39% | -$29.9M | 0.04% | 352 |
|
|
2013
Q2 | $73.3M | Buy |
+340,652
| New | +$72.8M | 0.06% | 227 |
|
Other funds holding BIIB
VCM
VPM
Royal Bank of Canada's BIIB Position: Q1 2026 in Review
Royal Bank of Canada reduced its Biogen (BIIB) stake by 1.9% in Q1 2026, selling an estimated $1.93M and leaving 531,377 shares worth $97.4M. The position accounts for 0.02% of the portfolio, ranked #637.
Royal Bank of Canada first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $177M in Q1 2018. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Royal Bank of Canada held 531,377 shares of Biogen worth $97.4M as of Q1 2026.
- Royal Bank of Canada sold 10,448 Biogen shares in Q1 2026, an estimated $1.93M.
- Biogen made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #637 holding.
- Royal Bank of Canada first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Biogen position peaked at $177M in Q1 2018.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.